These success, together with a former report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 guidance the concept of focusing on ACKR3 as a singular method to modulate the opioid program, which could open new therapeutic avenues for opioid-similar disorders. Research on conolidine is proscribed, https://why-should-i-use-conolidi22086.blogolize.com/a-review-of-conolidine-66477463